Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN48669688Phase 4Completed
Phase 4, randomised, open-label trial of permethrin in pediculosis capitis (2 arms), sponsored by WEPA Apotheken-Fachbedarf. Primary endpoint: Eradication of head louse infestation. Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN48669688.